A "systems medicine" approach to the study of non-alcoholic fatty liver disease.

Dig Liver Dis

General Medicine 2, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Italy. Electronic address:

Published: March 2016

The prevalence of fatty liver (steatosis) in the general population is rapidly increasing worldwide. The progress of knowledge in the physiopathology of fatty liver is based on the systems biology approach to studying the complex interactions among different physiological systems. Similarly, translational and clinical research should address the complex interplay between these systems impacting on fatty liver. The clinical needs drive the applications of systems medicine to re-define clinical phenotypes, assessing the multiple nature of disease susceptibility and progression (e.g. the definition of risk, prognosis, diagnosis criteria, and new endpoints of clinical trials). Based on this premise and in light of recent findings, the complex mechanisms involved in the pathology of fatty liver and their impact on the short- and long-term clinical outcomes of cardiovascular, metabolic liver diseases associated with steatosis are presented in this review using a new "systems medicine" approach. A new data set is proposed for studying the impairments of different physiological systems that have an impact on fatty liver in different subsets of subjects and patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2015.10.027DOI Listing

Publication Analysis

Top Keywords

fatty liver
24
"systems medicine"
8
medicine" approach
8
physiological systems
8
liver
7
fatty
6
systems
5
clinical
5
approach study
4
study non-alcoholic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!